epicatechin has been researched along with scopoletin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, FR; Hwang, TL; Lee, CL; Liao, YC; Wu, CC; Wu, YC | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Al-Asri, J; Fazekas, E; Görick, C; Gyémánt, G; Lehoczki, G; Melzig, MF; Mortier, J; Perdih, A; Wolber, G | 1 |
3 other study(ies) available for epicatechin and scopoletin
| Article | Year |
|---|---|
Ixorapeptide I and ixorapeptide II, bioactive peptides isolated from Ixora coccinea.
Topics: Cell Line, Tumor; Humans; Kaempferols; Luteolin; Magnetic Resonance Spectroscopy; Molecular Conformation; Pancreatic Elastase; Peptides; Platelet Aggregation Inhibitors; Rubiaceae; Structure-Activity Relationship; Superoxides | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
Topics: alpha-Amylases; Carbohydrates; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2015 |